AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

654.210

-12.420-1.86%

Number of Gainers:7

Number of Losers:16

Number of Flat:20

PE:- -

High:672.893

Open:666.621

Low:654.193

Close:666.631

Volume:53.15M

Turnover:150.21M

Market Cap:93.81B

Float Cap:90.67B

Loading ...

Paradigm Biopharmaceuticals - Clinical Review and Restructuring Process Expected to Take at Least Eight Weeks

THOMSON REUTERS

Paradigm Biopharmaceuticals - Securities Remain Suspended from Trading on ASX During Administration

THOMSON REUTERS

4DMedical And 2 Other Australian Growth Stocks To Own

Simply Wall St.

CSL Seqirus Expands U.S. Availability of Influenza Vaccine Following Successful Completion of the 2026/27 Manufacturing Campaign

THOMSON REUTERS

CSL Partners With Amazon Web Services

MT Newswires Live

CSL Ltd and AWS Collaborate to Advance Biopharmaceutical Research and Development

Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041

MT Newswires Live

CSL Partners with AWS to Apply AI, Cloud Tools in Biopharma R&D

CSL Ltd - Collaboration with Amazon Web Services

THOMSON REUTERS

In Clinical Development, CSL Working with AWS to Reduce Manual Effort in Areas Including Protocol Authoring, Others

THOMSON REUTERS

CSL Ltd - CSL and AWS Collaborate to Advance Biopharmaceutical R&D

THOMSON REUTERS

CSL Ltd - Collaboration with AWS to Apply Artificial Intelligence and Cloud Technologies to Support Co's Research & Clinical Development

THOMSON REUTERS

Mayne Pharma to Pay $650,000 to Settle US Generic Drug Claims

MT Newswires Live

Mayne Pharma Group - Settlement Made Without Admission of Liability or Wrongdoing by Mayne Pharma

THOMSON REUTERS

Mayne Pharma Group - Announces Agreement to Resolve Civil Complaint from 49 US States

THOMSON REUTERS

ASX Growth Stocks To Watch With Up To 28% Insider Ownership

Simply Wall St.

Elite Australian Growth Stocks To Own In September 2026

Simply Wall St.

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Paradigm Biopharmaceuticals to Return $2 Million of Funds to Obsidian Global

MT Newswires Live

Paradigm Biopharmaceuticals Ltd-Agreement to Return US$2M to Obsidian

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":654.21045,"timestamp":1790920799841,"preClose":666.6309,"halted":0,"volume":53151570,"delay":0,"changeRate":-0.018632,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-12.420471,"latestTime":"10-02 16:00:00 AEST","open":666.6212,"high":672.893,"low":654.19293,"amount":150213367,"amplitude":0.028052,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791154800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790899200000,1790920800000]],"turnoverRate":0.002113,"increases":6,"decrements":17,"flats":19,"marketCap":93808167218.5,"floatMarketCap":90665936927.125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":672.893,"amplitude":0.028052,"preClose":666.6309,"low":654.19293,"latestPrice":654.21045,"volume":53151570,"delay":0,"open":666.6212,"prevYearClose":644.3692,"prevWeekClose":662.842,"prevMonthClose":689.549,"prevQuarterClose":689.549,"fiveDayClose":662.842,"twentyDayClose":666.366,"sixtyDayClose":493.616,"secType":"PLATE","market":"AU","turnoverRate":0.002113,"marketCap":93808167218.5,"floatMarketCap":90665936927.125,"timestamp":1790920799841,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":7,"down":16,"flat":20},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671322394","title":"Paradigm Biopharmaceuticals - Clinical Review and Restructuring Process Expected to Take at Least Eight Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671322394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671322394?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671223910","title":"Paradigm Biopharmaceuticals - Securities Remain Suspended from Trading on ASX During Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671223910?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PAR.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671277550","title":"4DMedical And 2 Other Australian Growth Stocks To Own","url":"https://stock-news.laohu8.com/highlight/detail?id=2671277550","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671277550?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:21","pubTimestamp":1790724093,"startTime":"0","endTime":"0","summary":"Australia’s interest rate now sits at a 15 year high of 4.6%, which makes dependable earnings growth harder to find and more valuable when you do. Higher borrowing costs punish weak balance sheets, yet stronger businesses with solid finances and clear profit expansion stories can still build wealth. This article highlights three Australian high growth potential stocks from our healthy growth screen that fit that profile.\nThe three stocks covered below are a small sample, with the full healthy...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-and-2-other-australian-growth-stocks-to-own","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-and-2-other-australian-growth-stocks-to-own","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JOYT","IIGF.AU","GXDW","ZYAU.AU","BK7043","DECU","GIVE.AU","BK7508","E200.AU","OZF.AU","RGLO","EIGA.AU","VAS.AU","BK7096","GEAR.AU","SLF.AU","IMLC.AU","VGFPF","4DX.AU","QRE.AU","DACE.AU","XKO.AU","IISV.AU","BBOZ.AU","VAP.AU","BK7503","IOZ.AU","BEAR.AU","PMDE","NEU.AU","XJO.AU","STW.AU","XAO.AU","VOTE","OZR.AU","MP1.AU","QFN.AU","BK7094","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671179142","title":"CSL Seqirus Expands U.S. Availability of Influenza Vaccine Following Successful Completion of the 2026/27 Manufacturing Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2671179142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671179142?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:30","pubTimestamp":1790688611,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0VW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7511","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126476","title":"CSL Partners With Amazon Web Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126476","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671126476?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:15","pubTimestamp":1790648142,"startTime":"0","endTime":"0","summary":"CSL  partnered with Amazon Web Services to apply artificial intelligence and cloud technologies in advancing its biopharmaceutical research and clinical development, the biotechnology company said in a statement on Tuesday.The collaboration will enable scientists to connect and analyze data, identify targets sooner, accelerate timelines, and assess external opportunities efficiently, while fostering closer links between laboratory and computational work, the statement said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1988902786.USD","LU0053666078.USD","LU0342679015.USD","LU2860962120.EUR","LU0210533765.USD","LU1633808545.USD","SG9999001077.SGD","LU0154236417.USD","LU2250418816.HKD","LU2271345857.HKD","LU0109391861.USD","LU1116320901.HKD","LU0871640123.AUD","LU0061475181.USD","LU2462157665.USD","LU0149725797.USD","LU2360106780.USD","LU2089283258.USD","LU0354030438.USD","GB00BDT5M118.USD","LU1941712264.USD","LU0210536198.USD","SGXZ31699556.SGD","LU0157215616.USD","LU1720051017.SGD","LU1064131342.USD","IE00BJLML261.HKD","LU1934455194.USD","LU0494093205.USD","IE0004086264.USD","LU2505996509.AUD","IE00B4YYXB79.USD","LU1116320737.USD","LU2764263039.SGD","LU1941712348.USD","LU2471134523.USD","LU0823434583.USD","LU0158827948.USD","IE0034235303.USD","LU2023250843.SGD","LU0210528500.USD","LU0861579265.USD","SG9999015978.USD","LU2505996681.GBP","LU0345770308.USD","LU2746668461.USD","LU0889565833.HKD","LU0456855351.SGD","LU0788109477.HKD","LU2213496289.HKD","LU0072462426.USD","LU1201861249.SGD","LU1429558221.USD","ILDR","LU0466842654.USD","LU0784385170.HKD","LU1244550494.USD","LU1046421795.USD","LU1232071149.USD","LU1989764748.USD","LU0786609619.USD","LU1244550221.USD","LU0265550946.USD","LU0640476718.USD","LU1720051108.HKD","IE00BKDWB100.SGD","SG9999017495.SGD","LU2430703251.USD","BK4554","LU1301847155.USD","LU0320765059.SGD","LU2746668974.SGD","LU0943347566.SGD","LU2999663052.SGD","LU1674673691.USD","IE00BMPRXR70.SGD","LU2125154778.USD","BK7508","IE00BFSS8Q28.SGD","LU2065171402.SGD","LU2463028550.USD","LU2168564065.EUR","LU1868837300.USD","LU0648000940.SGD","BK7067","LU2471134952.CNY","LU2077746001.SGD","IE00B1BXHZ80.USD","LU2452424414.USD","IE00B1XK9C88.USD","LU1066053197.SGD","LU2552382215.SGD","LU0308772762.SGD","AMZZ","BK4579","IE000BZT7R73.USD","SG9999014880.SGD","LU0310800379.SGD","LU0957791311.USD","LU1917777945.USD","HK0000304805.HKD","LU2083900584.USD","LU0823421416.USD","LU1979441026.SGD","BK4220","LU0302445910.USD","LU2462591350.SGD","LU0082616367.USD","AMZG","LU0289960550.SGD","IE00BQXX3C00.GBP","BK4548","LU2637965513.SGD","LU0011850046.USD","LU2592432038.USD","LU1074936037.SGD","LU0354030511.USD","LU0174119429.USD","LU2896262040.SGD","LU1934455277.USD","BK4604","IE0002270589.USD","HULL","LU1883839398.USD","IE00B5949003.HKD","LU0096364046.USD","LU2764263203.CNY","LU2360032135.SGD","LU2063271972.USD","IE000F7OJYX1.SGD","CLIX","LU1868836591.USD","IE00BK4W5L77.USD","LU0965508806.USD","AMZO","LU0642271901.SGD","LU2065170008.USD","LU1366192091.USD","LU1261432733.SGD","LU2054465674.USD","SG9999018857.SGD","LU2361044865.SGD","LU0251131958.USD","LU1823568750.SGD","LU0029864427.USD","IE00BQXX3F31.USD","LU2236285917.USD","IE00B775H168.HKD","IE00BJTD4N35.SGD","LU0528227936.USD","LU2237957811.SGD","LU2487616109.SGD","IE00B3S45H60.SGD","LU1861558580.USD","IE00B19Z8W00.USD","IE0004091025.USD","LU1974910355.USD","BK4524","BK4533","LU0077335932.USD","BK4535","IE00BJJMRY28.SGD","LU0096362180.USD","LU0127658192.USD","LU1235294995.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","IE00BZ1G4Q59.USD","LU2028103732.USD","LU0175139822.USD","LU0345769631.USD","LU1366333091.USD","LU0211328371.USD","LU2417539215.USD","SG9999002232.USD","HK0000304797.USD","SG9999004303.SGD","RTH","LU0234572021.USD","LU0742534661.SGD","LU0708994859.HKD","BK4612","USAW.SI","LU2456880835.USD","LU0128525929.USD","LU2242650005.HKD","LU0276348264.USD","LU2087625088.SGD","LU0162691827.USD","LU2168564222.USD","LU0964807845.USD","LU1066051498.USD","IE00BWXC8680.SGD","LU0823411888.USD","LU2237957902.USD","AMZN","BK4561","LU0289941410.SGD","LU1066051811.HKD","LU2242649171.HKD","LU2108987350.USD","LU0323591593.USD","LU0097036916.USD","LU1804176565.USD","SGXZ23171101.USD","LU1551013342.USD","LU0072461881.USD","BK4592","LU0820561909.HKD","LU2362540622.SGD","IE000WAW04H5.SGD","LU1316542783.SGD","LU2106854487.HKD","LU0256863811.USD","LU2430703095.HKD","LU0267386448.USD","LU2750360641.GBP","LU0353189763.USD","AMAA","AMZP","LU0417517546.SGD","LU0314104364.USD","LU0985320562.USD","LU1153585028.USD","LU2357305700.SGD","LU1674673428.USD","LU2247934214.USD","LU1814569148.SGD","LU2362541273.HKD","LU0107464264.USD","IE00BN29S564.USD","IE00B775SV38.USD","BK4588","IE00BFSS7M15.SGD","LU1548497426.USD","SGXZ81514606.USD","BK4122","LU0048573561.USD","LU1868836914.USD","LU1935043452.HKD","IE000ITXATA3.USD","LU0348723411.USD","LU2264538146.SGD","LU2756315318.SGD","LU1201861165.SGD","LU0238689110.USD","SGXZ99366536.SGD","IE00BKPKM429.USD","SG9999002224.SGD","LU0203202063.USD","LU1037948897.HKD","LU1145028129.USD","BK4532","BK4559","LU2543165471.USD","SGXZ80539844.SGD","LU2211817866.USD","LU0061474705.USD","LU1791710582.SGD","IE00BYQQ9H92.USD","IE0003U64NQ7.SGD","IE000YTNTUN2.SGD","LU2087621335.USD","LU0965509010.AUD","LU1861127337.USD","IE0001KFT4U8.USD","IE00BMPRXQ63.HKD","BK4550","LU0234570918.USD","LU0070302665.USD","LU0390134368.USD","LU1496350502.SGD","LU2602419157.SGD","LU0208291251.USD","SGXZ51526630.SGD","LU0170899867.USD","LU1267930730.SGD","BK4581","LU2430703178.SGD","LU1914381329.SGD","LU2317271919.USD","IE00B19Z3B42.SGD","LU0211327993.USD","AMZU","HK0000532082.HKD","LU2023250330.USD","LU2168563687.JPY","LU1267930490.SGD","LU1084165304.USD","LU2275660780.HKD","IE00B5TLWC47.USD","LU0056508442.USD","IE0009G5SDU7.USD","LU1718418525.SGD","LU0949170426.SGD","LU2361045086.USD","BK4507","LU0345769128.USD","LU1935043536.SGD","LU0316494557.USD","SAMZNmain","LU0353189680.USD","LU0138981039.USD","LU1037948541.HKD","LU2097829019.USD","LU2552382058.USD","LU1989764664.SGD","IE0005OL40V9.USD","LU0133085943.USD","LU0823434740.USD","LU2462591277.SGD","LU0345774631.USD","AZYY","BK4543","LU0198837287.USD","LU0672654240.SGD","LU2168564495.EUR","LU1839511570.USD","SG9999000418.SGD","IE0004445239.USD","LU1691799644.USD","LU2065171311.SGD","LU1127390331.HKD","SG9999015952.SGD","IE0009356076.USD","BK7511","LU0784383803.USD","LU2750360997.AUD","LU1629891620.HKD","LU2362541513.USD","BK4538","IE00B3SWFQ91.USD","LU2954938101.SGD","LU0251142724.SGD","LU1935042215.USD","HK0000914686.HKD","LU0784384876.USD","BK4534","LU0310799852.SGD","LU0256863902.USD","LU1244550577.SGD","SG9999015945.SGD","LU0158827781.USD","LU1280957306.USD","LU0061474960.USD","IE00B19Z3581.USD","HK0000914660.USD","LU2023250504.SGD","IE000W1ABFV2.USD","LU2023251221.USD","LU2111349929.HKD","LU2720916845.USD","LU1815333072.USD","LU1551013425.SGD","LU2461242641.AUD","LU2552382132.HKD","BK4527","LU0787776722.HKD","LU0965509283.SGD","LU0784385840.USD","BK4503","LU1868837136.USD","LU2092627202.USD","IE0004445015.USD","LU2211815571.USD","LU0820562030.AUD","LU2265009873.SGD","IE00B7SZLL34.SGD","LU1880398471.USD","LU1791710400.SGD","AMZD","LU0980610538.SGD","LU2471134796.USD","LU1323610961.USD","LU1861559042.SGD","SG9999018865.SGD","LU0251132253.USD","LU0719512351.SGD","LU2326559502.SGD","LU1035775433.USD","LU0130102774.USD","IE00BKVL7J92.USD","LU0708995401.HKD","SG9999014898.SGD","LU0345770993.USD","LU1496350171.SGD","WANT","LU0724617625.USD","IE00BQXX3D17.EUR","LU0882574139.USD","ONLN","IE0000B7K699.USD","LU1435385759.SGD","AMZW","LU0345768740.USD","LU1066051225.USD","LU0965509101.SGD","IE000M9KFDE8.USD","CSL.AU","LU1119994496.HKD","LU0109392836.USD","LU0648001328.SGD","LU1935042991.SGD","LU1935042488.USD","LU0048584097.USD","LU0130103400.USD","BK7501","BK4566","IE000SO60NU8.SGD","LU0823421333.USD","LU2381873111.SGD","LU1880398554.USD","BK4551","BK4585","LU0079474960.USD","LU0080751232.USD","LU0312595415.SGD","LU2125154935.USD","SG9999014914.USD","LU0143551892.USD","LU0683600562.USD","LU2089284900.SGD","LU0345768153.USD","LU2065169927.USD","LU1934455863.HKD","SG9999014906.USD","OGIG","IE00BJTD4V19.USD","BK4598","LU2361044949.HKD","LU0215105999.USD","LU1803068979.SGD","LU0070217475.USD","LU1069344957.HKD","LU1868836757.USD","SG9999015986.USD","LU2756315664.SGD","LU0203201768.USD","LU0820561818.USD","IE00BFXG0V08.USD","LU0265550359.USD","LU2420271590.USD","IE00B4JS1V06.HKD","IE00B19Z8X17.USD","LU2092937148.SGD","SGXZ44715902.SGD","LU1267930573.SGD","LU2471134879.HKD","LU0345774391.USD","IE00BMPRXN33.USD","IE000MB6IJN5.SGD","LU1852331112.SGD","IE00B19Z9505.USD","IE000KEQY171.SGD","LU2237438978.USD","IE00BJJMRX11.SGD","BK4596","LU0320765489.SGD","LU1778281490.HKD","LU2764262908.HKD","LU1935043023.USD","LU2403377893.USD","LU0689472784.USD","LU2168564149.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671264546","title":"CSL Ltd and AWS Collaborate to Advance Biopharmaceutical Research and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2671264546","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671264546?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:58","pubTimestamp":1790647118,"startTime":"0","endTime":"0","summary":"Sept 29 (Reuters) - CSL Limited::*CSL AND AWS COLLABORATE TO ADVANCE BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT*COLLABORATION WITH AWS TO APPLY ARTIFICIAL INTELLIGENCE AND CLOUD TECHNOLOGIES TO SUPPOR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nRSD9wgM5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671261940","title":"Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2671261940","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671261940?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:25","pubTimestamp":1790645148,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  said partner Acadia Pharmaceuticals received a notice of allowance from the US Patent and Trademark Office for a new US patent covering weight-banded dosing of trofinetide, according to a Tuesday Australian bourse filing.The patent, once issued and with six months of pediatric exclusivity, is expected to extend US patent protection for trofinetide to March 28, 2041, nearly five years beyond the current protection period, the filing said.Trofinetide is marketed in the US under the brand names Daybue and Daybue Stix for patients aged two years and older with Rett syndrome, the filing added.The company's shares rose 2% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USRD","NEU.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671226543","title":"CSL Partners with AWS to Apply AI, Cloud Tools in Biopharma R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2671226543","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671226543?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:47","pubTimestamp":1790639236,"startTime":"0","endTime":"0","summary":"CSL partners with AWS to apply AI, cloud tools in biopharma R&DCSL entered a collaboration with AWS to apply AI and cloud tools across research and clinical development.Partnership targets faster targ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL47WYMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462591277.SGD","BK4503","LU2125154935.USD","SG9999014914.USD","LU0061474705.USD","SGXZ99366536.SGD","LU1116320901.HKD","LU1066051811.HKD","LU2461242641.AUD","IE00BQXX3C00.GBP","GB00BDT5M118.USD","LU1116320737.USD","LU0353189680.USD","LU0072461881.USD","CLIX","LU0788109477.HKD","LU2023250843.SGD","LU1935042215.USD","LU0345768740.USD","LU0965508806.USD","LU2750360997.AUD","OGIG","LU0289941410.SGD","LU1935043023.USD","SG9999015986.USD","IE0034235303.USD","LU0310799852.SGD","LU1323610961.USD","IE00B19Z8W00.USD","SG9999015978.USD","LU2543165471.USD","LU1035775433.USD","LU0784383803.USD","LU1267930730.SGD","BK4532","LU2999663052.SGD","BK4524","LU0353189763.USD","IE00BZ1G4Q59.USD","LU1778281490.HKD","BK4561","IE0009356076.USD","LU0320765489.SGD","AMZN","LU1868836591.USD","IE00B3SWFQ91.USD","AMZY","LU0157215616.USD","LU2471134796.USD","LU2362541513.USD","LU2420271590.USD","LU0061475181.USD","LU1267930573.SGD","IE00BJJMRY28.SGD","LU1435385759.SGD","LU2063271972.USD","AMZU","LU0494093205.USD","LU1880398554.USD","LU1988902786.USD","LU1366333091.USD","LU2361044949.HKD","LU0208291251.USD","LU0345774631.USD","IE00BJLML261.HKD","LU2471134523.USD","LU0823434583.USD","SG9999002232.USD","LU1791710582.SGD","LU2236285917.USD","LU1046421795.USD","BK4604","LU0210536198.USD","SG9999014906.USD","LU2087625088.SGD","IE00B19Z9505.USD","LU1914381329.SGD","LU2463028550.USD","LU2065171311.SGD","IE00B4YYXB79.USD","IE00B5949003.HKD","SG9999017495.SGD","LU1989764664.SGD","LU0787776722.HKD","LU1868837136.USD","SG9999001077.SGD","LU0154236417.USD","LU0345770308.USD","SG9999000418.SGD","LU0162691827.USD","LU2089283258.USD","LU0265550359.USD","LU0251131958.USD","LU1861559042.SGD","BK4507","LU2106854487.HKD","SGXZ31699556.SGD","LU1935042488.USD","IE00BK4W5M84.HKD","LU1244550221.USD","LU2023251221.USD","LU0784384876.USD","LU1674673691.USD","LU0882574139.USD","AMAA","LU0070217475.USD","LU1074936037.SGD","LU1935043452.HKD","LU1823568750.SGD","SG9999015952.SGD","LU2750360641.GBP","LU0964807845.USD","IE00BFSS8Q28.SGD","LU0985320562.USD","LU0138981039.USD","IE00BJTD4N35.SGD","LU2764263039.SGD","IE0004445239.USD","LU2896262040.SGD","IE00BJTD4V19.USD","LU0823421333.USD","LU0957791311.USD","IE00B19Z3581.USD","LU2077746001.SGD","IE00BK4W5L77.USD","IE00BFSS7M15.SGD","LU0107464264.USD","IE0000B7K699.USD","LU0820562030.AUD","LU0943347566.SGD","LU1934455277.USD","LU0133085943.USD","LU0070302665.USD","IE00B5TLWC47.USD","LU0314104364.USD","LU1261432733.SGD","IE0004091025.USD","LU0320765059.SGD","LU2125154778.USD","IE000W1ABFV2.USD","SG9999015945.SGD","LU0215105999.USD","LU0267386448.USD","IE00B1XK9C88.USD","LU2471134952.CNY","BK4559","LU0820561818.USD","BK4543","HULL","LU0820561909.HKD","LU2092937148.SGD","LU2357305700.SGD","LU1979441026.SGD","LU0096364046.USD","LU2361045086.USD","LU0683600562.USD","BK4588","LU1066051225.USD","LU0109391861.USD","IE000ITXATA3.USD","LU1280957306.USD","LU1551013425.SGD","LU2271345857.HKD","LU2237957811.SGD","LU2242649171.HKD","LU1852331112.SGD","WANT","LU1145028129.USD","BK4566","IE00B4JS1V06.HKD","IE00BJJMRX11.SGD","LU1267930490.SGD","BK7508","LU0053666078.USD","LU1496350171.SGD","LU0316494557.USD","LU0390134368.USD","LU0724617625.USD","BK4122","IE00BN29S564.USD","LU1974910355.USD","LU2487616109.SGD","LU1235294995.USD","IE000WAW04H5.SGD","BK4581","LU2211817866.USD","LU1201861165.SGD","LU0056508442.USD","IE00B19Z8X17.USD","LU2637965513.SGD","SGXZ51526630.SGD","LU0048573561.USD","LU0689472784.USD","LU0672654240.SGD","LU0323591593.USD","LU1861558580.USD","LU0310800379.SGD","LU2264538146.SGD","LU2362541273.HKD","LU1674673428.USD","IE00BQXX3D17.EUR","IE0002270589.USD","LU2860962120.EUR","LU2237957902.USD","BK4612","IE000KEQY171.SGD","LU0011850046.USD","LU0048584097.USD","LU1804176565.USD","LU0784385170.HKD","LU1868837300.USD","LU0354030438.USD","LU1119994496.HKD","LU2471134879.HKD","LU0354030511.USD","LU0238689110.USD","LU2764263203.CNY","LU0175139822.USD","LU0072462426.USD","LU2065169927.USD","IE00B775SV38.USD","LU2326559502.SGD","IE000F7OJYX1.SGD","HK0000914660.USD","LU0256863811.USD","LU0079474960.USD","LU0302445910.USD","IE00BMPRXN33.USD","LU1629891620.HKD","LU2456880835.USD","LU0823411888.USD","LU2381873111.SGD","LU0251142724.SGD","LU0871640123.AUD","LU1917777945.USD","LU2360106780.USD","AMZO","LU2250418816.HKD","IE00BFXG0V08.USD","LU0719512351.SGD","LU0234570918.USD","BK4548","LU1301847155.USD","LU2028103732.USD","LU1839511570.USD","LU0289960550.SGD","LU2211815571.USD","LU0466842654.USD","LU1633808545.USD","IE0005OL40V9.USD","LU2097829019.USD","LU1718418525.SGD","LU1244550577.SGD","LU0096362180.USD","AZYY","LU1429558221.USD","LU2452424414.USD","LU2092627202.USD","LU0143551892.USD","LU1868836757.USD","LU0345768153.USD","LU0708994859.HKD","LU0823434740.USD","LU2265009873.SGD","SGXZ80539844.SGD","LU0980610538.SGD","ONLN","LU0211327993.USD","LU0648001328.SGD","IE0003U64NQ7.SGD","LU0082616367.USD","IE00B7SZLL34.SGD","USAW.SI","IE00BKPKM429.USD","SG9999004303.SGD","AMZW","LU2317271919.USD","LU0965509101.SGD","LU2108987350.USD","LU0203202063.USD","LU0528227936.USD","LU1791710400.SGD","IE00B19Z3B42.SGD","LU0642271901.SGD","LU1064131342.USD","LU2023250330.USD","IE00BYQQ9H92.USD","LU2592432038.USD","IE0009G5SDU7.USD","LU0345769631.USD","BK4550","LU2462157665.USD","LU0130103400.USD","IE00B7KXQ091.USD","SG9999014898.SGD","AMZP","SG9999018865.SGD","AMZG","LU0097036916.USD","LU2505996681.GBP","LU2023250504.SGD","LU0128525929.USD","LU0742534661.SGD","LU2360032135.SGD","CSL.AU","LU0640476718.USD","LU0158827781.USD","LU1496350502.SGD","LU1037948541.HKD","LU1989764748.USD","LU0345774391.USD","LU1232071149.USD","LU1720051108.HKD","LU2168564065.EUR","LU0127658192.USD","LU1244550494.USD","LU0784385840.USD","LU2168564222.USD","BK4551","LU0198837287.USD","LU0345770993.USD","LU2417539215.USD","IE000YTNTUN2.SGD","LU1720051017.SGD","LU1691799644.USD","HK0000914686.HKD","LU1037948897.HKD","AMZD","LU2764262908.HKD","BK4585","LU2361044865.SGD","LU1316542783.SGD","LU1127390331.HKD","LU2552382132.HKD","LU2746668461.USD","LU0170899867.USD","SG9999002224.SGD","BK4554","LU1941712264.USD","HK0000532082.HKD","IE00BQXX3F31.USD","IE00BKDWB100.SGD","LU0080751232.USD","LU1366192091.USD","LU0211328371.USD","ILDR","LU2065171402.SGD","LU1883839398.USD","LU0029864427.USD","LU2403377893.USD","LU2430703095.HKD","SGXZ81514606.USD","LU1934455863.HKD","LU2430703178.SGD","LU2552382058.USD","LU0061474960.USD","LU2602419157.SGD","SGXZ23171101.USD","HK0000304805.HKD","LU2054465674.USD","LU0889565833.HKD","LU0251132253.USD","BK4533","BK7067","LU0342679015.USD","LU2756315318.SGD","IE00BWXC8680.SGD","LU0348723411.USD","LU1935043536.SGD","SG9999018857.SGD","LU2462591350.SGD","LU0708995401.HKD","IE000BZT7R73.USD","IE00B775H168.HKD","LU1201861249.SGD","LU0203201768.USD","LU2065170008.USD","LU1069344957.HKD","LU0077335932.USD","BK4220","LU2746668974.SGD","LU2954938101.SGD","BK7511","LU0861579265.USD","LU2083900584.USD","LU2087621335.USD","IE0004086264.USD","HK0000304797.USD","BK7501","LU2168563687.JPY","LU0210533765.USD","LU0965509010.AUD","BK4535","IE000M9KFDE8.USD","IE00B3S45H60.SGD","AMZZ","LU0234572021.USD","LU0276348264.USD","BK4592","LU0965509283.SGD","IE00B1BXHZ80.USD","LU2242650005.HKD","LU2275660780.HKD","LU2430703251.USD","LU0312595415.SGD","LU2720916845.USD","LU1861127337.USD","LU1066051498.USD","BK4579","LU1548497426.USD","LU1935042991.SGD","LU2168564149.EUR","LU1153585028.USD","LU2213496289.HKD","SGXZ44715902.SGD","LU1815333072.USD","LU0256863902.USD","LU0823421416.USD","BK4538","LU1066053197.SGD","LU1551013342.USD","IE0001KFT4U8.USD","LU0210528500.USD","LU2111349929.HKD","LU1941712348.USD","LU0174119429.USD","BK4598","RTH","LU0417517546.SGD","LU1868836914.USD","LU2168564495.EUR","LU2237438978.USD","LU1934455194.USD","SG9999014880.SGD","LU1803068979.SGD","LU0456855351.SGD","IE0004445015.USD","LU2552382215.SGD","LU0308772762.SGD","IE00BKVL7J92.USD","LU0158827948.USD","LU0949170426.SGD","LU0265550946.USD","LU2247934214.USD","LU1814569148.SGD","LU1880398471.USD","LU2505996509.AUD","LU0149725797.USD","LU2756315664.SGD","IE000MB6IJN5.SGD","IE00BMPRXR70.SGD","LU2089284900.SGD","IE000SO60NU8.SGD","IE00BMPRXQ63.HKD","LU0786609619.USD","BK4596","BK4527","LU0130102774.USD","LU1084165304.USD","BK4534","SAMZNmain","LU0109392836.USD","LU0345769128.USD","LU2362540622.SGD","LU0648000940.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671626514","title":"CSL Ltd - Collaboration with Amazon Web Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2671626514","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671626514?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671482265","title":"In Clinical Development, CSL Working with AWS to Reduce Manual Effort in Areas Including Protocol Authoring, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2671482265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671482265?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671265151","title":"CSL Ltd - CSL and AWS Collaborate to Advance Biopharmaceutical R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2671265151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671265151?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7511","BK7067","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671145265","title":"CSL Ltd - Collaboration with AWS to Apply Artificial Intelligence and Cloud Technologies to Support Co's Research & Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2671145265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671145265?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7511","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670631402","title":"Mayne Pharma to Pay $650,000 to Settle US Generic Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2670631402","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670631402?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:15","pubTimestamp":1790554551,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  has agreed to pay $650,000 to resolve civil claims brought by attorneys general from 49 US states and territories as part of a broader investigation into the generic pharmaceutical industry, according to a Monday Australian bourse filing.The settlement, which does not involve any admission of liability or wrongdoing, aims to avoid further legal expenses, management distraction, and uncertainty, per the filing.The company said the settlement requires only limited administrative measures, including maintaining its existing antitrust compliance policy and issuing annual compliance notices for two years, without imposing any restrictions on its business operations.The settlement remains subject to final court approval, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670747404","title":"Mayne Pharma Group - Settlement Made Without Admission of Liability or Wrongdoing by Mayne Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2670747404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670747404?lang=en_us&edition=fundamental","pubTime":"2026-09-28 07:45","pubTimestamp":1790552739,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260927:nFWN45I00I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670404742","title":"Mayne Pharma Group - Announces Agreement to Resolve Civil Complaint from 49 US States","url":"https://stock-news.laohu8.com/highlight/detail?id=2670404742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670404742?lang=en_us&edition=fundamental","pubTime":"2026-09-28 07:45","pubTimestamp":1790552739,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260927:nFWN45I00I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670392032","title":"ASX Growth Stocks To Watch With Up To 28% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2670392032","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670392032?lang=en_us&edition=fundamental","pubTime":"2026-09-28 03:07","pubTimestamp":1790536078,"startTime":"0","endTime":"0","summary":"In the current Australian market landscape, a weaker overnight session in the US has cast a shadow over technology and growth-sensitive sectors on the ASX, though potential stability in miners and energy stocks could offer some relief. Amid these fluctuations, identifying growth companies with significant insider ownership can be appealing as it often signals confidence from those closest to the business.","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice1-card/1788945089957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice1-card/1788945089957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-dur/duratec-shares/news/asx-growth-stocks-to-watch-with-up-to-28-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-dur/duratec-shares/news/asx-growth-stocks-to-watch-with-up-to-28-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7023","IIGF.AU","ZYAU.AU","SKS.AU","GIVE.AU","AEM.AU","BK7508","BTL.AU","BK7501","BK7017","E200.AU","OZF.AU","WZR.AU","EIGA.AU","BK7095","VAS.AU","BK7096","AV1.AU","PDI.AU","GEAR.AU","SLF.AU","IMLC.AU","BK7005","QRE.AU","BK7104","DACE.AU","XKO.AU","BK7062","IISV.AU","P1E.AU","BBOZ.AU","ELS.AU","CDIG","VAP.AU","IOZ.AU","BEAR.AU","XJO.AU","BK7093","FRS.AU","BK7084","BK7110","BK7016","STW.AU","XAO.AU","OZR.AU","SPL.AU","QFN.AU","AR1.AU","DUR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670707554","title":"Elite Australian Growth Stocks To Own In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670707554","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670707554?lang=en_us&edition=fundamental","pubTime":"2026-09-26 11:28","pubTimestamp":1790393289,"startTime":"0","endTime":"0","summary":"Rising long term bond yields have pushed borrowing costs higher, which puts pressure on many growth stocks that rely heavily on cheap debt. That makes financially healthier Australian growth stories more interesting right now. This screener focuses on businesses where analysts see strong earnings growth potential and balance sheets that can better handle higher rates. In this article, you will see three of the strongest candidates from that group.\nThe three Australian stocks highlighted below...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/elite-australian-growth-stocks-to-own-in-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/elite-australian-growth-stocks-to-own-in-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBOZ.AU","VTHR","OZR.AU","IISV.AU","STW.AU","BK7094","QRE.AU","E200.AU","BK7096","IIGF.AU","DACE.AU","OZF.AU","4DX.AU","GIVE.AU","QFN.AU","VAP.AU","IOZ.AU","IMLC.AU","XJO.AU","BEAR.AU","BK7043","GEAR.AU","AIPO","XAO.AU","BK7508","CHAT","NEU.AU","BK7503","EIGA.AU","AGIX","ARTY","SLF.AU","QTOC","XKO.AU","MP1.AU","VAS.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670208384","title":"NASDAQ Trade Halt Halt News Pending at 07:50 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2670208384","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670208384?lang=en_us&edition=fundamental","pubTime":"2026-09-26 07:50","pubTimestamp":1790380200,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:50 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nAQN2MKW2S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMM.AU","IMMP","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669541554","title":"Paradigm Biopharmaceuticals to Return $2 Million of Funds to Obsidian Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2669541554","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669541554?lang=en_us&edition=fundamental","pubTime":"2026-09-24 14:12","pubTimestamp":1790230359,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  agreed to return the $2 million of funds it recently received from Obsidian Global under a fourth-tranche drawdown of its convertible note facility, according to a Thursday filing with the Australian bourse.The 2 million convertible notes issued in connection with the drawdown will be cancelled, and no premium, redemption amount, or other amount is payable by Paradigm under the arrangement, per the filing.The development follows the interim efficacy result for Paradigm's phase 3 trial of injectable pentosan polysulfate sodium for the treatment of knee osteoarthritis failing to reach the threshold required for the study to proceed.The company is reviewing data to better understand what impact that trial result will have on its financial position and future operations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451310","title":"Paradigm Biopharmaceuticals Ltd-Agreement to Return US$2M to Obsidian","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451310?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:25","pubTimestamp":1790227524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUE2K4JSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PAR.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":75,"code":"91000000","status":"200"}]}}